LLY Feb 2023 310.000 put
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 02:27PM EST. Market open.
| Previous Close | 1.4800 |
| Open | 1.0900 |
| Bid | 1.2700 |
| Ask | 1.5000 |
| Strike | 310.00 |
| Expire Date | 2023-02-17 |
| Day's Range | 0.9900 - 1.3600 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 952 |
- Zacks
Eli Lilly (LLY) Lymphoma Candidate Pirtobrutinib Gets FDA Nod
The FDA approves Eli Lilly's Jaypirca (pirtobrutinib) under an accelerated approval pathway as a treatment for mantle cell lymphoma (MCL).
- Reuters
UPDATE 1-FDA approves Eli Lilly's blood cancer drug
Eli Lilly and Co said on Friday the U.S. health regulator approved its drug for the treatment of a rare form of blood cancer. The Food and Drug Administration gave accelerated approval to Jaypirca for the treatment of adults mantle cell lymphoma after at least two lines of therapy.
- Zacks
FDA Pulls EUA Granted to AstraZeneca's (AZN) Evusheld
AstraZeneca's (AZN) Evusheld is no longer authorized for use in the United States after laboratory data showed that it does not neutralize Omicron subvariants.
© 2023 Yahoo. All rights reserved.
